[HTML][HTML] Less is more: reconsidering the need for regular use of diagnostic whole body radioiodine scintigraphy in the follow-up of differentiated thyroid cancer

C Pirich, G Schweighofer-Zwink - European Journal of Nuclear Medicine …, 2017 - Springer
By far, differentiated thyroid cancer (DTC) is the most common form of thyroid cancer (TC)
accounting for about 90% of all TC in most industrialized countries [1]. Incidence has …

Imaging surveillance of differentiated thyroid cancer

NA Johnson, SO LeBeau, ME Tublin - Radiologic Clinics, 2011 - radiologic.theclinics.com
Differentiated thyroid cancer (DTC) is typically an indolent disease with a very low disease-
specific mortality. Although most cases are cured with a combination of surgical resection …

Nuclear medicine in the assessment of differentiated thyroid cancer

GC Rutherford, B Franc, A O'Connor - Clinical radiology, 2008 - Elsevier
Despite modern multi-modality treatment, 10–30% of patients treated for differentiated
thyroid cancer (DTC) ultimately develop local recurrence or metastatic disease. These …

The role of nuclear medicine in differentiated thyroid cancer

S Kohlfürst - Wiener Medizinische Wochenschrift, 2012 - infona.pl
In differentiated thyroid cancer (DTC) nuclear medicine is able to cover the spectrum from
diagnosis and treatment to follow up keeping patient's management in one institution …

[HTML][HTML] SNMMI/EANM practice guideline vs. ETA Consensus Statement: differences and similarities in approaching differentiated thyroid cancer management—the …

P Petranović Ovčariček, MC Kreissl… - European journal of …, 2022 - Springer
During the last few years, especially since the American Thyroid Association guidelines was
released in 2015, there has been an intense debate on the management of thyroid cancer …

[HTML][HTML] Recurrence incidence in differentiated thyroid cancers and the importance of diagnostic iodine-131 scintigraphy in clinical follow-up

F Hatipoğlu, İ Karapolat, Ö Ömür, A Akgün… - Molecular imaging …, 2016 - ncbi.nlm.nih.gov
Objective: Differentiated thyroid cancers (DTC) are tumors with good prognosis. However,
local recurrence or distant metastasis can be observed. In our study, we aimed to investigate …

Differentiated thyroid carcinoma: Incremental diagnostic value of 131I SPECT/CT over planar whole body scan after radioiodine therapy

V Zilioli, A Peli, MB Panarotto, G Magri, A Alkraisheh… - Endocrine, 2017 - Springer
The purpose of this prospective study was to determine the incremental diagnostic value of
single photon emission computed tomography/computed tomography with iodine-131 over …

[HTML][HTML] New opportunities for dosimetric approach in patients with differentiated thyroid cancer

L Piscopo, E Zampella, M Klain - European Journal of Nuclear Medicine …, 2024 - Springer
In the adult population, the differentiated thyroid cancer (DTC) is the most frequent
endocrine neoplasm [1]. According to the American Thyroid Association (ATA) guidelines, in …

[HTML][HTML] Radioiodine treatment after surgery for differentiated thyroid cancer: a reasonable option

J Clerc, FA Verburg, AM Avram, L Giovanella… - European Journal of …, 2017 - Springer
Until recently, the usual treatment for differentiated thyroid cancers (DTC) with a size> 1.0 cm
undisputedly consisted of total or near-total thyroidectomy followed by radioiodine …

Value of diagnostic radioiodine whole-body scanning after initial therapy in patients with differentiated thyroid cancer at intermediate and high risk for recurrence

PW Rosario, MS Furtado, AFCM Filho, RX Lacerda… - Thyroid, 2012 - liebertpub.com
Background: Diagnostic radioiodine whole-body scanning (DxWBS) in combination with
stimulated thyroglobulin (Tg)(ie, measurement after levothyroxine [L-T4] withdrawal or …